In this episode, healthcare investor and strategist Maryann Umoren Selfe is joined by Matthias Wipf, CEO of Swiss medtech company Momm Diagnostics, to examine the systemic gaps in how we identify and fund life-saving healthcare infrastructure for women.
Blindspot Capital features Momm Diagnostics: Can We Finally Detect Preeclampsia Before It’s Too Late?
